{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:13:33Z","timestamp":1779200013435,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,1,10]],"date-time":"2015-01-10T00:00:00Z","timestamp":1420848000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00431-014-2479-z","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T03:31:43Z","timestamp":1420774303000},"page":"911-917","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome"],"prefix":"10.1007","volume":"174","author":[{"given":"Diana","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Zawadynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure F.","family":"Pittet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Chevalley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Girardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paloma","family":"Parvex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,10]]},"reference":[{"issue":"11","key":"2479_CR1","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00467-014-2834-3","volume":"29","author":"G Aceto","year":"2014","unstructured":"Aceto G, D\u2019Addato O, Messina G et al (2014) Bone health in children and adolescents with steroid-sensitive nephrotic syndrome assessed by DXA and QUS. Pediatr Nephrol 29(11):2147\u20132155","journal-title":"Pediatr Nephrol"},{"key":"2479_CR2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0889-8529(05)70348-0","volume":"25","author":"DB Allen","year":"1996","unstructured":"Allen DB (1996) Growth suppression by glucocorticoid therapy. Endocrinol Metab Clin N Am 25:699\u2013717","journal-title":"Endocrinol Metab Clin N Am"},{"key":"2479_CR3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1542\/peds.5.3.486","volume":"5","author":"LA Barness","year":"1950","unstructured":"Barness LA, Moll GH, Janeway CA (1950) Nephrotic syndrome I. Natural history of the disease. Pediatrics 5:486\u2013503","journal-title":"Pediatrics"},{"key":"2479_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00467-009-1249-z","volume":"25","author":"M Bianchi","year":"2010","unstructured":"Bianchi M, Baim S, Bishop N et al (2010) Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents. Pediatr Nephrol 25:37\u201347","journal-title":"Pediatr Nephrol"},{"key":"2479_CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1749-6632.2002.tb04204.x","volume":"966","author":"E Canalis","year":"2002","unstructured":"Canalis E, Delany AM (2002) Mechanisms of glucocorticoid action in bone. Ann N Y Acad Sci 966:73\u201381","journal-title":"Ann N Y Acad Sci"},{"key":"2479_CR6","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","volume":"18","author":"E Canalis","year":"2007","unstructured":"Canalis E, Mazziotti G, Giustina A et al (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319\u20131328","journal-title":"Osteoporos Int"},{"key":"2479_CR7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00467-003-1142-0","volume":"18","author":"TL Donatti","year":"2003","unstructured":"Donatti TL, Koch VH, Fujimura MD et al (2003) Growth in steroid-responsive nephrotic syndrome: a study of 85 pediatric patients. Pediatr Nephrol 18:789\u2013795","journal-title":"Pediatr Nephrol"},{"key":"2479_CR8","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00467-003-1176-3","volume":"18","author":"F Emma","year":"2003","unstructured":"Emma F, Sesto A, Rizzoni G (2003) Long-term linear growth of children with severe steroid-responsive nephrotic syndrome. Pediatr Nephrol 18:783\u2013788","journal-title":"Pediatr Nephrol"},{"key":"2479_CR9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(85)90851-7","volume":"2","author":"KD Foote","year":"1985","unstructured":"Foote KD, Brocklebank JT, Meadow SR (1985) Height attainment in children with steroid-responsive nephrotic syndrome. Lancet 2:917\u2013919","journal-title":"Lancet"},{"key":"2479_CR10","first-page":"569","volume":"288","author":"M Friedman","year":"1966","unstructured":"Friedman M, Strang LB (1966) Effect of long-term corticosteroids and corticotrophin on the growth of children. Lancet 288:569\u2013572","journal-title":"Lancet"},{"key":"2479_CR11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-119-10-199311150-00001","volume":"119","author":"RF Laan","year":"1993","unstructured":"Laan RF, van Riel PL, van de Putte LB et al (1993) Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study. Ann Intern Med 119:963\u2013968","journal-title":"Ann Intern Med"},{"key":"2479_CR12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/adc.43.231.589","volume":"43","author":"CN Lam","year":"1968","unstructured":"Lam CN, Arneil GC (1968) Long-term dwarfing effects of corticosteroid treatment for childhood nephrosis. Arch Dis Child 43:589\u2013594","journal-title":"Arch Dis Child"},{"key":"2479_CR13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0889-8529(05)70017-7","volume":"27","author":"NE Lane","year":"1998","unstructured":"Lane NE, Lukert B (1998) The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin N Am 27:465\u2013483","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"Suppl 2","key":"2479_CR14","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1542\/peds.2006-2023J","volume":"119","author":"MB Leonard","year":"2007","unstructured":"Leonard MB (2007) Glucocorticoid-induced osteoporosis in children: impact of the underlying disease. Pediatrics 119(Suppl 2):S166\u2013S174","journal-title":"Pediatrics"},{"key":"2479_CR15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-3955(03)00113-5","volume":"49","author":"MB Leonard","year":"2002","unstructured":"Leonard MB, Zemel BS (2002) Current concepts in pediatric bone disease. Pediatr Clin N Am 49:143\u2013173","journal-title":"Pediatr Clin N Am"},{"key":"2479_CR16","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJMoa040367","volume":"351","author":"MB Leonard","year":"2004","unstructured":"Leonard MB, Feldman HI, Shults J et al (2004) Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. N Engl J Med 351:868\u2013875","journal-title":"N Engl J Med"},{"key":"2479_CR17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","volume":"28","author":"RM Lombel","year":"2012","unstructured":"Lombel RM, Gipson DS, Hodson EM (2012) Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol 28:415\u2013426","journal-title":"Pediatr Nephrol"},{"key":"2479_CR18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00467-012-2304-8","volume":"28","author":"RM Lombel","year":"2012","unstructured":"Lombel RM, Hodson EM, Gipson DS (2012) Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. Pediatr Nephrol 28:409\u2013414","journal-title":"Pediatr Nephrol"},{"key":"2479_CR19","first-page":"21","volume":"21","author":"A Madani","year":"2011","unstructured":"Madani A, Umar S, Taghaodi R et al (2011) The effect of long-term steroid therapy on linear growth of nephrotic children. Iran J Pediatr 21:21\u201327","journal-title":"Iran J Pediatr"},{"key":"2479_CR20","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s12098-009-0256-1","volume":"76","author":"O Mishra","year":"2009","unstructured":"Mishra O, Meena S, Singh S et al (2009) Bone mineral density in children with steroid-sensitive nephrotic syndrome. Indian J Pediatr 76:1237\u20131239","journal-title":"Indian J Pediatr"},{"key":"2479_CR21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/adc.87.2.93","volume":"87","author":"T Mushtaq","year":"2002","unstructured":"Mushtaq T, Ahmed S (2002) The impact of corticosteroids on growth and bone health. Arch Dis Child 87:93\u201396","journal-title":"Arch Dis Child"},{"issue":"2","key":"2479_CR22","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00198-013-2466-7","volume":"25","author":"V Phan","year":"2014","unstructured":"Phan V, Blydt-Hansen T, Feber J et al (2014) Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome. Osteoporos Int 25(2):627\u2013637","journal-title":"Osteoporos Int"},{"key":"2479_CR23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/adc.2007.129957","volume":"95","author":"J Simmonds","year":"2010","unstructured":"Simmonds J, Grundy N, Trompeter R et al (2010) Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome. Arch Dis Child 95:146\u2013149","journal-title":"Arch Dis Child"},{"key":"2479_CR24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/archpedi.1967.02090210107011","volume":"113","author":"LF Soyka","year":"1967","unstructured":"Soyka LF (1967) Treatment of the nephrotic syndrome in childhood: use of an alternate-day prednisone regimen. Am J Dis Child 113:693\u2013701","journal-title":"Am J Dis Child"},{"key":"2479_CR25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/jbmr.1785","volume":"28","author":"A Tsampalieros","year":"2013","unstructured":"Tsampalieros A, Gupta P, Denburg MR et al (2013) Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome. J Bone Miner Res 28:480\u2013488","journal-title":"J Bone Miner Res"},{"key":"2479_CR26","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","volume":"15","author":"TP Staa Van","year":"2000","unstructured":"Van Staa TP, Leufkens HG, Abenhaim L et al (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993\u20131000","journal-title":"J Bone Miner Res"},{"key":"2479_CR27","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200084","volume":"13","author":"TP Staa van","year":"2002","unstructured":"van Staa TP, van Staa TP, van Staa TP et al (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777\u2013787","journal-title":"Osteoporos Int"},{"key":"2479_CR28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1359\/jbmr.2003.18.5.913","volume":"18","author":"TP Staa van","year":"2003","unstructured":"van Staa TP, Cooper C, Leufkens H et al (2003) Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res 18:913\u2013918","journal-title":"J Bone Miner Res"},{"key":"2479_CR29","volume-title":"WHO Child Growth Standards: length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development","author":"WHO Multicentre Growth Reference Study Group","year":"2006","unstructured":"WHO Multicentre Growth Reference Study Group (2006) WHO Child Growth Standards: length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. World Health Organization, Geneva"},{"key":"2479_CR30","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1210\/jc.2011-1111","volume":"96","author":"BS Zemel","year":"2011","unstructured":"Zemel BS, Kalkwarf HJ, Gilsanz V et al (2011) Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab 96:3160\u20133169","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-014-2479-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-014-2479-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-014-2479-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T12:42:00Z","timestamp":1650976920000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-014-2479-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,10]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["2479"],"URL":"https:\/\/doi.org\/10.1007\/s00431-014-2479-z","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,10]]}}}